Search Within

David R D'Adamo

Formats
  1. Meeting Abstract (19)
  2. Journal Article (18)
Groups
  1. Department of Medicine (27)
  2. Solid Tumor Oncology Division (26)
  3. Sarcoma Service (19)
  4. GSK Faculty (16)
  5. Tow Center for Developmental Oncology (TCDO) (16)
  6. Department of Pathology and Laboratory Medicine (15)

More Groups

People
  1. Robert Maki (27)
  2. Mary Keohan (19)
  3. Gary Schwartz (16)
  4. Cristina Antonescu (14)
  5. Samuel Singer (7)
  6. David Kelsen (6)

More People

Years
  1. 2013 (2)
  2. 2012 (2)
  3. 2011 (8)
  4. 2010 (6)
  5. 2009 (4)
  6. 2008 (4)

More Years

Publications
  1. Journal of Clinical Oncology (23)
  2. Cancer (3)
  3. Clinical Cancer Research (3)
  4. Sarcoma (2)
  5. Advances in Therapy (1)
  6. Annals of Oncology (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (23)
  2. American Association for Cancer Research (3)
  3. Wiley Blackwell (3)
  4. Hindawi Publishing Corporation (2)
  5. Oxford University Press (2)
  6. Massachusetts Medical Society (1)

More Publishers

Results (37)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pure primary prostatic osteosarcoma arising in a non-irradiated prostate
    Journal Article

    Rabbani, F.; Fine, R. G.; D'adamo, D.; Edgar, M.; Akin, O.; Paty, P.
    Urologia Internationalis (2009)

    Fulltext@MSK | Save
  • Advances in the treatment of gastrointestinal stromal tumor
    Journal Article

    D'adamo, D.
    Advances in Therapy (2009)

    Fulltext@MSK | Save
  • Activity of sorafenib (SOR) in patients (pts) with imatinib (IM) and sunitinib (SU)-resistant (RES) gastrointestinal stromal tumors (GIST): A phase II trial of the University of Chicago Phase II Consortium
    Meeting Abstract

    Wiebe, L.; Kasza, K. E.; Maki, R. G.; D'Adamo, D. R.; Chow, W. A.; Wade, J. L.; Agamah, E.; Stadler, W. M.; Vokes, E. E.; Kindler, H. L.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Continuous daily dosing (CDD) of sunitinib (SU) in patients with metastatic soft tissue sarcomas (STS) other than GIST: Results of a phase II trial
    Meeting Abstract

    Keohan, M. L.; Morgan, J. A.; D'Adamo, D. R.; Harmon, D.; Butrynski, J. E.; Wagner, A. J.; Schwartz, G. K.; Maki, R. G.; Demetri, G. D.; George, S.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Updated results of a phase II study of oral multi-kinase inhibitor sorafenib in sarcomas, CTEP study #7060
    Meeting Abstract

    Maki, R. G.; Keohan, M. L.; Undevia, S. D.; Livingston, M.; Cooney, M. M.; Elias, A.; Saulle, M. F.; Wright, J. J.; D'Adamo, D. R.; Schuetze, S. M.; more...
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Extraskeletal myxoid chondrosarcoma: A retrospective review from 2 referral centers emphasizing long-term outcomes with surgery and chemotherapy
    Journal Article

    Drilon, A.; Popat, S.; Bhuchar, G.; D'adamo, D. R.; Keohan, M. L.; Fisher, C.; Antonescu, C. R.; Singer, S.; Brennan, M. F.; Judson, I.; more...
    Cancer (2008)

    Fulltext@MSK | Save
  • Clinical results of a phase II study of sorafenib in patients (pts) with non-GIST sarcomas (CTEP study #7060)
    Meeting Abstract

    D'Adamo, D. R.; Keohan, M.; Schuetze, S.; Undevia, S.; Livingston, M.; Cooney, M.; Kraft, A.; Saulle, M.; Schwartz, G. K.; Maki, R. G.; more...
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Sarcoma
    Journal Article

    Skubitz, K. M.; D'adamo, D. R.
    Mayo Clinic Proceedings (2007)

    Fulltext@MSK | Save
  • Sorafenib inhibits the imatinib-resistant KITT670I gatekeeper mutation in gastrointestinal stromal tumor
    Journal Article

    Guo, T.; Agaram, N. P.; Wong, G. C.; Hom, G.; D'adamo, D.; Maki, R. G.; Schwartz, G. K.; Veach, D.; Clarkson, B. D; Singer, S.; more...
    Clinical Cancer Research (2007)

    Fulltext@MSK | Save
  • Final results of a multicenter phase II study of irinotecan (CPT), cisplatin (CIS), and bevacizumab (BEV) in patients with metastatic gastric or gastroesophageal (GEJ) adenocarcinoma (NCI #6447)
    Meeting Abstract

    Shah, M. A.; Ramanathan, R. K.; Ilson, D.; Randazzo, J.; Schwartz, G. K.; Tse, A.; D'adamo, D.; Levner, A.; Capanu, M.; Kelsen, D. P.
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save